Thrive Capital Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1845943
FORT WASHINGTON, PA
Position in NBIX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,622,715
+$951,517 QoQ
Shares Held
27,428
-1.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#219
of 768 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrive Capital Management, LLC holds $13,446,022 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (34.4% of the industry book) .
All Filings in NBIX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,622,715 | 27,428 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,671,198 | 27,867 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,386,900 | 23,880 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,290,580 | 16,317 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,932,735 | 15,377 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $464,741 | 4,202 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,525,524 | 11,176 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $467,217 | 4,055 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $547,651 | 3,978 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $241,773 | 1,753 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||